On ECHEMI
Home > Drugs > Primary cardiac rhabdomyosarcoma
Primary cardiac rhabdomyosarcoma
Primary cardiac rhabdomyosarcoma (primary rhabdomyosarcoma of heart) is the most common cardiac malignant tumor except for angiosarcoma that arises from myocardial tissue. Cardiac rhabdomyosarcoma is considered to be a developmental abnormality, which may be differentiated from primitive mesenchymal cells and is mostly congenital. From a pathological point of view, rhabdomyosarcoma is a common and highly malignant mesenchymal tumor that often occurs in the limbs and is mostly located in the muscle or its vicinity. It is nodular or lobed, and the cross-section is fish-like, grayish white or grayish red. Hemorrhage and necrosis are often seen. Under the microscope, the tumor is mainly composed of striated muscle cells at various stages of differentiation.
  • Site of disease:

    heart
  • Infectious :

    Not contagious
  • Frequent population:

    30-40 years old
  • Related symptoms:

    Difficulty breathing Hepatosplenomegaly Heart murmur Chest pain Dyspnea
  • Concurrent disease:

Related Drugs
Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Henan Kelun Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Shanxi Shuguang Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.